Results 41 to 50 of about 24,968 (201)
Background: Lenvatinib combined with a PD-1 inhibitor has obtained a satisfactory antitumor effect in several solid tumors. However, the efficacy and tumor response of lenvatinib with a PD-1 inhibitor in advanced intrahepatic cholangiocarcinoma still ...
Lulu Xie +10 more
doaj +1 more source
Serum Markers of Intrahepatic Cholangiocarcinoma [PDF]
Cholangiocarcinoma (CCA) is a relatively rare type of primary liver cancer that originates in the bile duct epithelium. It is an aggressive malignancy typified by unresponsiveness to chemotherapy and radiotherapy. Despite advances in radiologic techniques and laboratory diagnostic test, the diagnosis of CCA remains highly challenging.
MALAGUARNERA, GIULIA ANNA MARIA +5 more
openaire +2 more sources
Intrahepatic cholangiocarcinoma is a highly fatal tumor characterized by an abundant stromal environment. Cancer‐associated fibroblasts play key roles in tumor growth and invasiveness and have been regarded as a potential therapeutic target.
Meng Sha +7 more
doaj +1 more source
Mass-forming intrahepatic cholangiocarcinoma presenting with painful obstructive hemobilia
We report a very rare case of acute obstructive hemobilia caused by bleeding of a mass-forming intrahepatic cholangiocarcinoma in a 75-year old man. The prompt complete emergency diagnosis was made by ultrasound and confirmed by MDCT.
B Coulier +3 more
doaj +1 more source
Clear cell papillary cholangiocarcinoma: A case report with review of literature
Clear cell papillary cholangiocarcinoma is a rare variant of intrahepatic cholangiocarcinoma with only nine reported cases in the literature. This tumor needs to be differentiated from clear cell variant of hepatocellular carcinoma and other metastatic ...
Rachna Khera +3 more
doaj +1 more source
INTRAHEPATIC CHOLANGIOCARCINOMA
Intrahepatic cholangiocarcinoma (ICC) is a rare but aggressive malignancy arising from the epithelial cells of the intrahepatic bile ducts. The disease is characterized by complex diagnosis, high mortality, and limited therapeutic options at advanced stages.
Banina E., Burgoci S.
+6 more sources
Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?
Background: The potential benefit of surgical resection of intrahepatic cholangiocarcinoma in patients with locoregionally advanced disease has not been definitively determined.
Patrick J. Sweigert, MD +7 more
doaj +1 more source
ABSTRACT Objective The prognosis of glioblastoma (GBM) remains highly unfavorable, largely due to high tumor heterogeneity and an immunosuppressive microenvironment. However, the functional role of PANoptosis in this context is poorly understood. Methods Patients were stratified via K‐means clustering. A risk score model was constructed using prognosis‐
Langfei Tian +6 more
wiley +1 more source
Prostate-specific membrane antigen (PSMA) targeted tracers show increased uptake in several malignancies, indicating a potential for peptide radioligand therapy. Intra-arterial injection of radiotracers can increase the therapeutic window.
Mara Marieke Katrien Veenstra +6 more
doaj +1 more source
Systematic characterization of the liver‐resident microbiota in advanced metabolic dysfunction‐associated steatotic liver disease (MASLD) reveals a consistent depletion of Bacteroides uniformis (B. uniformis) in both hepatic and gut microbial communities. Oral gavage of B.
Haiyang Liu +4 more
wiley +1 more source

